These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 6154164)

  • 21. Enhanced in vitro macrophage cytotoxicity against interferon-treated B16 melanoma cells.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1995; 9(4):139-45. PubMed ID: 8844338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy.
    Saji H; Song W; Furumoto K; Kato H; Engleman EG
    Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.
    Abdel-Wahab Z; Dar M; Osanto S; Fong T; Vervaert CE; Hester D; Jolly D; Seigler HF
    Cancer Gene Ther; 1997; 4(1):33-41. PubMed ID: 9012449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
    Silagi S; Calvelli TA
    Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
    Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
    Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization.
    Staib L; Harel W; Mitchell MS
    Cancer Res; 1993 Mar; 53(5):1113-21. PubMed ID: 8439956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expressing melanoma cells.
    Hyoudou K; Nishikawa M; Umeyama Y; Kobayashi Y; Yamashita F; Hashida M
    Clin Cancer Res; 2004 Nov; 10(22):7685-91. PubMed ID: 15570002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
    Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN
    J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
    Fidler IJ; Schroit AJ
    J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
    Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG
    Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice.
    Koga M; Kai H; Egami K; Murohara T; Ikeda A; Yasuoka S; Egashira K; Matsuishi T; Kai M; Kataoka Y; Kuwano M; Imaizumi T
    Biochem Biophys Res Commun; 2008 Jan; 365(2):279-84. PubMed ID: 17991428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphokine-mediated immunotherapy studies in mouse tumor systems.
    Papermaster BW; Gilliland CD; McEntire JE; Smith ME; Buchok SJ
    Cancer; 1980 Mar; 45(5 Suppl):1248-53. PubMed ID: 7357517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 6-hydroxydopamine on tumor growth.
    Chelmicka-Szorc E; Arnason BG
    Cancer Res; 1976 Jul; 36(7 PT 1):2382-4. PubMed ID: 1277142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different susceptibilities of cultured mouse cell lines to mouse interferon.
    Tsuruo T; Iida H; Tsukagoshi S; Oku T; Kishida T
    Gan; 1982 Feb; 73(1):42-7. PubMed ID: 6180951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discussion paper: a tumor-inhibiting lymphokine from tuberculous mice.
    Salvin SB; Youngner JS; Nishio J; Neta R
    Ann N Y Acad Sci; 1976; 276():369-72. PubMed ID: 800323
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucan immunotherapy as adjunct in the surgical excision of experimental melanoma.
    Browder W; McNamee R; Di Luzio N
    Surg Forum; 1977; 28():171-3. PubMed ID: 617407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.